
Temple publishes first validation study of wearable
By Abha Lohia · Editor ·
Temple: valuation and funding and every story →
Founded 2025
- Temple makes a wearable device that tracks brain blood flow from the side of the head
- It released a preprint study showing its metric correlates with Doppler readings in 20 adults
- The company raised about ₹493 crore earlier in 2026 and plans to ship devices by year-end
What happened
- Temple released its first validation study of its wearable device.
- The study was published as a preprint and submitted for peer review.
- It involved 23 healthy adults; data from 20 participants were analysed.
- Temple's brain flow metric showed a median within-subject correlation of ~0.8 with middle cerebral artery blood-flow velocity measured by Doppler ultrasound.
- During a postural test, heart rate declined while cerebral blood-flow velocity increased; Temple's metric moved in the same direction as the Doppler reading.
- The study does not establish the ability to measure absolute cerebral blood flow or diagnose medical conditions.
- Further validation studies of Brain Flow and Entropy metrics are underway.
- Temple is offering device loans to qualified researchers.
Why it matters
- This is Temple's first public evidence that its wearable can track brain blood flow.
- The study provides initial validation but is not yet peer-reviewed.
- Temple raised ~₹493 crore earlier in 2026 from Peak XV Partners, Steadview Capital, NK Squared, and Deepinder Goyal.
- The company's valuation nearly doubled to $375 million as part of an ESOP liquidity programme for early employees.
- Temple also acquired London-based longevity medicine practice Longevous for an undisclosed amount.
The business
- Temple is developing a wearable device that continuously tracks signals associated with cerebral blood flow.
- It measures 'brain flow' from the side of the head.
- The company reduced the wearable size to less than half of the earlier version.
- Temple is preparing to open preorders and expects to begin shipping the device before the end of 2026.
- It raised ~₹493 crore earlier in 2026 at a valuation of ~₹1,700 crore (~$204 million).
- The valuation later nearly doubled to $375 million as part of an ESOP liquidity programme.
- Temple acquired London-based longevity medicine practice Longevous for an undisclosed amount.
The founders
- Deepinder Goyal is also the founder of Zomato.
- He is a founder of Temple.
In numbers
23 healthy adultsStudy participants · 2026
20Analysed participants · 2026
~0.8Median within-subject correlation · 2026
~₹493 CrFunding raised earlier in 2026
~₹1,700 Cr (~$204 Mn)Valuation at funding round · 2026
$375 MnValuation after ESOP liquidity · 2026
What happens next
- Further validation studies of Brain Flow and Entropy metrics are underway.
- Temple is offering device loans to qualified researchers.
- The company is preparing to open preorders and expects to begin shipping the device before the end of 2026.
Earlier rounds
- 2026 · ~₹493 Cr · led by Peak XV Partners, Steadview Capital, NK Squared, Deepinder Goyal
Words to know
- preprint
- A version of a scientific paper that is shared publicly before it has been reviewed by other experts (peer review).
- Doppler ultrasound
- A medical imaging technique that uses sound waves to measure blood flow in blood vessels.
- ESOP liquidity programme
- A programme that allows employees to sell their stock options (ESOPs) for cash, often by the company buying them back or arranging a secondary sale.
- longevity medicine
- Medical practice focused on extending healthy lifespan and delaying age-related diseases.
The numbers around it
Temple has 2 funding rounds in StopDown's archive, $54M raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 28 February 2026 | friends-and-family | $54M | Deepinder Goyal |
| 5 February 2026 | pre-Series A | $3.3 Mn | V3 Ventures |
Healthcare & Life Sciences in September 2026: 11 rounds with a disclosed amount, $114 million in all; the biggest was Ultrahuman ($70 mn). Every sector this year →
Other articles talking about it
Terms in this story
- Medical device vs wellness wearable: In India a health wearable is treated as a medical device when its maker says it can diagnose, monitor, treat or prevent a disease. A gadget sold only for general fitness or wellness sits outside those rules, but its claims are still policed by consumer law.
Read next
NewsDoctors question Temple wearable's brain-flow claimsTemple makes a ₹85,000 wearable that tracks body signals, including blood flow near the head, and pairs the readings with AI insightsFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Temple → · All startup news on 7 September 2026 →
Is this Temple? Get your “Featured on StopDown” badge →